Who’s Hired? Pfenex’ Lucy Joins Lykan Bioscience

As Samsung Biologics Names New President And CEO

 
• By Akriti Seth

Pfenex founder and chief business officer Patrick Lucy has left the company to join Lykan Bioscience. Meanwhile, Samsung Biologics has announced the appointment of a new president and CEO, as the Australian generics and biosimilars association appoints a new chair.

People Blocks Executives
Pfenex and Samsung Biologics see changes at key leadership positions • Source: Shutterstock

More from Leadership

More from Generics Bulletin